IL10 and Sepsis: Although in animal sepsis models, the use of specific neutralizing antibodies blocking the activity of TNF-α (Lv et al., 2014) and IL-10 (Kalechman et al., 2002) significantly improved the prognosis of sepsis, neutralizing antibodies to TNF-α in clinical trials did not yield satisfactory results (Lv et al., 2014).